Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Higher transparency typically signals stronger quality control processes, including: Verified purity levels (often 99%+ via HPLC analysis) Clearly identified third-party laboratory testing Batch-level traceability and verification codes Consistent and accessible documentation While lower pricing may be attractive, limited transparency can make it difficult to independently confirm product consistency
Common sites for self-injection are the thigh (vastus lateralis muscle) or the hip area
The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
Removal from Category 2 does not render these bulk drug substances eligible for compounding under section 503A
However, as with any bioactive compound, some risks and precautions apply
BPC-157 + TB-500 (10mg Blend) Dosage Protocol Soft-tissue repair blend BPC-157 5mg + TB-500 5mg in one combined vial (1:1)
US$ 28.55
US$ 25.96
US$ 26.74
US$ 28.31
US$ 23.27
